Scot Sedlacek

2.4k citations

41 papers · 1.8k indexed · h-index 19

Co-authors: Pamela Wolfe Henry J. Thompson Kathryn B. Horwitz Jerianne Heimendinger John Bryant Barry C. Lembersky Norman Wolmark Greg Yothers
Topics: Breast Cancer Treatment Studies (16 papers)Cancer Treatment and Pharmacology (9 papers)HER2/EGFR in Cancer Research (8 papers)
Cited by: Cancer Research Biochemistry Oncology
Journals: Journal of Clinical Oncology PLoS ONE American Journal of Clinical Nutrition
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Scot Sedlacek

41 papers receiving 1.7k citations

Peers

Countries citing papers authored by Scot Sedlacek

Since Specialization

Citations

This map shows the geographic impact of Scot Sedlacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot Sedlacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot Sedlacek more than expected).

Fields of papers citing papers by Scot Sedlacek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot Sedlacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot Sedlacek. The network helps show where Scot Sedlacek may publish in the future.

Co-authorship network of co-authors of Scot Sedlacek

This figure shows the co-authorship network connecting the top 25 collaborators of Scot Sedlacek. A scholar is included among the top collaborators of Scot Sedlacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot Sedlacek. Scot Sedlacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Randomized, Double-Blind, Placebo-Controlled Investigation of Selenium Supplementation in Women at Elevated Risk for Breast Cancer: Lessons for Re-Emergent Interest in Selenium and Cancer 2022 ·Biomedicines ·Henry J. Thompson,Scot Sedlacek,(unknown),Pamela Wolfe,John N. McGinley	4
2	Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study 2019 ·The Oncologist ·Vicky Jones,Kristi McIntyre,Devchand Paul,Sharon Wilks,(unknown),Scot Sedlacek,Anton Melnyk,(unknown),Yunfei Wang,(unknown),Joyce O’Shaughnessy	15
3	Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer 2017 ·Clinical Breast Cancer ·Cynthia Osborne,(unknown),Charles F. Eisenbeis,Frankie A. Holmes,Marcus A. Neubauer,(unknown),(unknown),S. Vukelja,Sharon Wilks,Mary Ann Allison,(unknown),Scot Sedlacek,Yunfei Wang,Lina Asmar,Joyce O’Shaughnessy	7
4	Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine 2015 ·Clinical Cancer Research ·Joyce O’Shaughnessy,Hartmut Koeppen,Yuanyuan Xiao,Mark R. Lackner,Devchand Paul,Christopher Stokoe,John Pippen,(unknown),Frankie A. Holmes,Svetislava J. Vukelja,(unknown),Scot Sedlacek,Ragene Rivera,Robert J. Brooks,Kristi McIntyre,Carrie Brownstein,Silke Hoersch,Joanne L. Blum,Stephen E. Jones	37
5	Weight Loss Interventions for Breast Cancer Survivors: Impact of Dietary Pattern 2015 ·PLoS ONE ·Henry J. Thompson,Scot Sedlacek,Mary C. Playdon,Pamela Wolfe,John N. McGinley,Devchand Paul,Susan G. Lakoski	11
6	Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study 2013 ·The Lancet Oncology ·(unknown),(unknown),Devchand Paul,Scot Sedlacek,Anne Favret,Ira Gore,Deborah Lindquist,Frankie A. Holmes,Mary Ann Allison,(unknown),(unknown),Svetislava J. Vukelja,Michael S. Steinberg,Christopher Stokoe,(unknown),Yunfei Wang,Lina Asmar,Nicholas J. Robert,Joyce O’Shaughnessy	92
7	Effect of dietary patterns differing in carbohydrate and fat content on blood lipidand glucose profiles based on weight-loss success of breast-cancer survivors 2012 ·Breast Cancer Research ·Henry J. Thompson,Scot Sedlacek,Devchand Paul,Pamela Wolfe,John N. McGinley,Mary C. Playdon,(unknown),(unknown),(unknown)	20
8	Accelerated Partial Breast Intensity-Modulated Radiotherapy in Women Who Have Prior Breast Augmentation 2011 ·Clinical Breast Cancer ·Charles E. Leonard,(unknown),(unknown),(unknown),(unknown),Terese I. Kaske,Lora D. Barke,Scot Sedlacek,(unknown),Dennis L. Carter	3
9	Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol 2011 ·BMC Cancer ·Scot Sedlacek,Mary C. Playdon,Pamela Wolfe,John N. McGinley,(unknown),(unknown),Weiqin Jiang,Zongjian Zhu,Henry J. Thompson	18
10	PD07-03: Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) Plus Trastuzumab (HER TC) in HER2−Positive Early Stage Breast Cancer Patients. 2011 ·Cancer Research ·SE Jones,(unknown),D Paul,Ruth Oratz,Scot Sedlacek,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Christopher Stokoe,(unknown),(unknown),(unknown),Lina Asmar,N. J. Robert,Joyce O’Shaughnessy	2
11	The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer 2009 ·Breast Cancer Research and Treatment ·Cynthia R. Osborne,(unknown),Scot Sedlacek,Devchand Paul,Frankie A. Holmes,Svetislava J. Vukelja,(unknown),Sharon Wilks,(unknown),(unknown),Wally Meyer,Joyce O’Shaughnessy	8
12	Cardiac Safety Results of a Phase II Trial of Adjuvant Docetaxel/Cyclophosphamide Plus Trastuzumab (Her TC) in HER2+ Early Stage Breast Cancer Patients. 2009 ·Cancer Research ·(unknown),Stephen E. Jones,(unknown),(unknown),Ruth Oratz,Devchand Paul,Scot Sedlacek,(unknown),(unknown),Ramón Portillo,(unknown),(unknown),Lina Asmar,J. O’Shaughnessy,Nicholas J. Robert	2
13	Predictors for Clinical Outcomes After Accelerated Partial Breast Intensity-Modulated Radiotherapy 2008 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Dennis L. Carter,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Terese I. Kaske,Devchand Paul,Scot Sedlacek,Charles E. Leonard	10
14	Dietary Botanical Diversity Affects the Reduction of Oxidative Biomarkers in Women due to High Vegetable and Fruit Intake 2006 ·Journal of Nutrition ·Henry J. Thompson,Jerianne Heimendinger,(unknown),Caitlin O’Neill,(unknown),(unknown),Pamela Wolfe,Scot Sedlacek,Zongjian Zhu,Weiqin Jiang	50
15	8-Isoprostane F2α excretion is reduced in women by increased vegetable and fruit intake 2005 ·American Journal of Clinical Nutrition ·Henry J. Thompson,Jerianne Heimendinger,Scot Sedlacek,Albert D. Haegele,(unknown),Caitlin O’Neill,(unknown),Pamela Wolfe,Zongjian Zhu,Weiqin Jiang	65
16	Lumpectomy and Breast Radiotherapy in Breast Cancer Patients with a Family History of Breast Cancer, Ovarian Cancer, or Both 2002 ·The Breast Journal ·Charles E. Leonard,Scot Sedlacek,Howard Shapiro,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	1
17	Clinical observations of axillary involvement for tubular, lobular, and ductal carcinomas of the breast 1999 ·Journal of Surgical Oncology ·Charles E. Leonard,(unknown),Howard Shapiro,Mary Corkill,Chris Gonzales,(unknown),Kathryn H. Howell,(unknown),Scot Sedlacek	6
18	Promoting Cancer Screening among the First-Degree Relatives of Breast and Colorectal Cancer Patients: The Design of Two Randomized Trials 1999 ·Preventive Medicine ·Alfred C. Marcus,Dennis J. Ahnen,Gary Cutter,Ned Calonge,Sarah Russell,Scot Sedlacek,Marie Wood,David Manchester,(unknown),Worta McCaskill‐Stevens,Diane L. Fairclough,(unknown),Lari Wenzel,(unknown)	16
19	Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage 1999 ·Carcinogenesis ·Henry J. Thompson,Jerianne Heimendinger,(unknown),Scot Sedlacek,Cynthia Dormer Gillette,Cian O’Neill,Pamela Wolfe,Colleen Conry	163
20	First-Line and Salvage Therapy of Metastatic Breast Cancer with Mitomycin/Vinblastine 1993 ·Oncology ·Scot Sedlacek	14

About Scot Sedlacek

Scot Sedlacek is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Cancer Research (712 citations), Biochemistry (229 citations) and Oncology (909 citations). Scot Sedlacek has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Pamela Wolfe, Henry J. Thompson, Kathryn B. Horwitz, Jerianne Heimendinger, John Bryant, Barry C. Lembersky, Norman Wolmark, Greg Yothers, Louis Fehrenbacher and Eleftherios P. Mamounas. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact